BDAB.F Stock Overview
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Boule Diagnostics AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr3.51 |
| 52 Week High | kr3.51 |
| 52 Week Low | kr3.51 |
| Beta | 0.61 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -87.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| BDAB.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 1.5% | 2.0% |
| 1Y | n/a | -2.0% | 22.3% |
Return vs Industry: Insufficient data to determine how BDAB.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how BDAB.F performed against the US Market.
Price Volatility
| BDAB.F volatility | |
|---|---|
| BDAB.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BDAB.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BDAB.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1956 | 200 | Jesper Soderqvist | www.boule.com |
Boule Diagnostics AB (publ), a diagnostics company, develops, manufactures, and markets instruments and consumable products for blood diagnostics. The company provides hematology analyzers, reagents, blood controls and calibrators, and reagents rotors, as well as cleaning products under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer and diagnostics systems under the Exigo brand. It sells its products directly in Sweden and the United States, as well as through distributors internationally.
Boule Diagnostics AB (publ) Fundamentals Summary
| BDAB.F fundamental statistics | |
|---|---|
| Market cap | US$37.88m |
| Earnings (TTM) | US$1.49m |
| Revenue (TTM) | US$52.10m |
25.3x
P/E Ratio0.7x
P/S RatioIs BDAB.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BDAB.F income statement (TTM) | |
|---|---|
| Revenue | kr558.69m |
| Cost of Revenue | kr321.68m |
| Gross Profit | kr237.01m |
| Other Expenses | kr220.98m |
| Earnings | kr16.03m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Jul 24, 2023
| Earnings per share (EPS) | 0.41 |
| Gross Margin | 42.42% |
| Net Profit Margin | 2.87% |
| Debt/Equity Ratio | 32.0% |
How did BDAB.F perform over the long term?
See historical performance and comparison